Granvil CP[au] - Search Results

Year	Number of Results
1993	1
1994	4
1996	2
1997	1
1999	3
2000	1
2001	1
2002	1
2003	2
2008	1
2009	1
2023	0

1

Stereoselective separations of chiral anticancer drugs and their application to pharmacodynamic and pharmacokinetic studies.

Wainer IW, Granvil CP. Wainer IW, et al. Among authors: granvil cp. Ther Drug Monit. 1993 Dec;15(6):570-5. doi: 10.1097/00007691-199312000-00021. Ther Drug Monit. 1993. PMID: 8122296 Review.

2

Pharmacokinetics of (R)- and (S)-cyclophosphamide and their dechloroethylated metabolites in cancer patients.

Williams ML, Wainer IW, Granvil CP, Gehrcke B, Bernstein ML, Ducharme MP. Williams ML, et al. Among authors: granvil cp. Chirality. 1999;11(4):301-8. doi: 10.1002/(SICI)1520-636X(1999)11:4<301::AID-CHIR7>3.0.CO;2-R. Chirality. 1999. PMID: 10224657

3

Ifosfamide stereoselective dichloroethylation and neurotoxicity.

Wainer IW, Ducharme J, Granvil CP, Trudeau M, Leyland-Jones B. Wainer IW, et al. Among authors: granvil cp. Lancet. 1994 Apr 16;343(8903):982-3. doi: 10.1016/s0140-6736(94)90109-0. Lancet. 1994. PMID: 7909040 No abstract available.

4

Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.

Woodland C, Ito S, Granvil CP, Wainer IW, Klein J, Koren G. Woodland C, et al. Among authors: granvil cp. Life Sci. 2000 Nov 24;68(1):109-17. doi: 10.1016/s0024-3205(00)00915-2. Life Sci. 2000. PMID: 11132240

5

Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.

Proksch JW, Granvil CP, Siou-Mermet R, Comstock TL, Paterno MR, Ward KW. Proksch JW, et al. Among authors: granvil cp. J Ocul Pharmacol Ther. 2009 Aug;25(4):335-44. doi: 10.1089/jop.2008.0116. J Ocul Pharmacol Ther. 2009. PMID: 19492955 Clinical Trial.

6

Quantitative determination of besifloxacin, a novel fluoroquinolone antimicrobial agent, in human tears by liquid chromatography-tandem mass spectrometry.

Arnold DR, Granvil CP, Ward KW, Proksch JW. Arnold DR, et al. Among authors: granvil cp. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 May 1;867(1):105-10. doi: 10.1016/j.jchromb.2008.03.025. Epub 2008 Apr 1. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18417430

7

4-Hydroxylation of debrisoquine by human CYP1A1 and its inhibition by quinidine and quinine.

Granvil CP, Krausz KW, Gelboin HV, Idle JR, Gonzalez FJ. Granvil CP, et al. J Pharmacol Exp Ther. 2002 Jun;301(3):1025-32. doi: 10.1124/jpet.301.3.1025. J Pharmacol Exp Ther. 2002. PMID: 12023534

8

Metabolic fate of methyl n-butyl ketone, methyl isobutyl ketone and their metabolites in mice.

Granvil CP, Sharkawi M, Plaa GL. Granvil CP, et al. Toxicol Lett. 1994 Feb 15;70(3):263-7. doi: 10.1016/0378-4274(94)90120-1. Toxicol Lett. 1994. PMID: 8284793

9

Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.

Granvil CP, Madan A, Sharkawi M, Parkinson A, Wainer IW. Granvil CP, et al. Drug Metab Dispos. 1999 Apr;27(4):533-41. Drug Metab Dispos. 1999. PMID: 10101149

10

The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse.

Corchero J, Granvil CP, Akiyama TE, Hayhurst GP, Pimprale S, Feigenbaum L, Idle JR, Gonzalez FJ. Corchero J, et al. Among authors: granvil cp. Mol Pharmacol. 2001 Dec;60(6):1260-7. doi: 10.1124/mol.60.6.1260. Mol Pharmacol. 2001. PMID: 11723233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results